UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease

Cancer, 2016-02, Vol.122 (3), p.378-385

2016

Volltextzugriff (PDF)

Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study

Breast cancer research and treatment, 2015-09, Vol.153 (2), p.397-405

2015

Volltextzugriff (PDF)

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.106-117

2020

Volltextzugriff (PDF)

Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.79-90

2020

Volltextzugriff (PDF)

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.22-36

2020

Volltextzugriff (PDF)

Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium

Sleep (New York, N.Y.), 2024-06, Vol.47 (6)

2024

Volltextzugriff (PDF)

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.37-48

2020

Volltextzugriff (PDF)

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.49-59

2020

Volltextzugriff (PDF)

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Alzheimer's & dementia, 2020-01, Vol.16 (1), p.11-21

2020

Volltextzugriff (PDF)

Frontal lobe 1 H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers

Neurology, 2019-08, Vol.93 (8), p.e758

2019

Volltextzugriff (PDF)

Baseline characteristics of the North American prodromal Synucleinopathy cohort

Annals of clinical and translational neurology, 2023-04, Vol.10 (4), p.520-535

2023

Volltextzugriff (PDF)

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers

Journal of neuroimaging, 2019-09, Vol.29 (5), p.624-629

2019

Volltextzugriff (PDF)

Abstract P2-09-04: Measurements of advocate participation in and contributions to the Mayo Clinic breast cancer SPORE

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P2-P2-09-04

2015

Volltextzugriff (PDF)

MR SPECTROSCOPY FROM FRONTAL LOBE AND POSTERIOR CINGULATE GYRUS IN ASYMPTOMATIC AND SYMPTOMATIC MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P876-P877

2018

Volltextzugriff (PDF)

P2‐430: MR SPECTROSCOPY FROM FRONTAL LOBE AND POSTERIOR CINGULATE GYRUS IN ASYMPTOMATIC AND SYMPTOMATIC MICROTUBULE‐ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_16), p.P876-P877

2018

Volltextzugriff (PDF)

Complex Fibroadenoma and Breast Cancer Risk: A Mayo Clinic Benign Breast Disease Cohort Studya

Breast cancer research and treatment, 2015-08, Vol.153 (2), p.397-405

2015

Volltextzugriff (PDF)

P2‐314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_14), p.P707-P708

2019

Volltextzugriff (PDF)

THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P707-P708

2019

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease

Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study

The North American Prodromal Synucleinopathy (NAPS) Consortium: Baseline neuropsychological findings in 136 participants

Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium

Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology

Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium

Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint

Frontal lobe 1 H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers

Baseline characteristics of the North American prodromal Synucleinopathy cohort

The North American Prodromal Synucleinopathy (NAPS) Consortium: Baseline neuropsychological findings in 136 participants: Neuropsychology/Early detection of cognitive decline with neuropsychological tests

Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers

Abstract P2-09-04: Measurements of advocate participation in and contributions to the Mayo Clinic breast cancer SPORE

MR SPECTROSCOPY FROM FRONTAL LOBE AND POSTERIOR CINGULATE GYRUS IN ASYMPTOMATIC AND SYMPTOMATIC MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS

P2‐430: MR SPECTROSCOPY FROM FRONTAL LOBE AND POSTERIOR CINGULATE GYRUS IN ASYMPTOMATIC AND SYMPTOMATIC MICROTUBULE‐ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS

ACCELERATED NEUROCHEMICAL CHANGES PRIOR TO PHENOCONVERSION TO FRONTOTEMPORAL LOBAR DEGENERATION IN PRESYMPTOMATIC MICROTUBULE-ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS: A LONGITUDINAL MRS STUDY

P1‐420: ACCELERATED NEUROCHEMICAL CHANGES PRIOR TO PHENOCONVERSION TO FRONTOTEMPORAL LOBAR DEGENERATION IN PRESYMPTOMATIC MICROTUBULE‐ASSOCIATED PROTEIN TAU (MAPT) MUTATION CARRIERS: A LONGITUDINAL MRS STUDY

Complex Fibroadenoma and Breast Cancer Risk: A Mayo Clinic Benign Breast Disease Cohort Studya

P2‐314: THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS

QUALITY OF LIFE AMONG SUBJECTS AND INFORMANTS IN FAMILIAL FRONTOTEMPORAL DEMENTIA: PRELIMINARY DATA IN THE LEFFTDS COHORT

PHENOCONVERSION FROM ASYMPTOMATIC TO MINIMALLY SYMPTOMATIC FTLD: PRELIMINARY DATA IN THE LEFFTDS COHORT

Suchergebnisse filtern